Čes. stomatol. Prakt. zub. lék. (Czech Dental Journal) 2011; 111(3): 71-77
Oral Compliacation after Bone Marrow Transplantation
- 1 Klinika ústní, čelistní a obličejové chirurgie FN, Olomouc
- 2 Hematoonkologická klinika FN, Olomouc
- 3 Klinika zubního lékařství LF UP a FN, Olomouc
The bone marrow transplantation is a curative method in leukemia, lymphomas, immunodeficient states and solid tumors. Graft versus host disease (GVHD) is a significant complication in patients after bone marrow transplantion, most frequently affected of intestine, liver, skin and oral mucosa. Oral mucosa damage is presented by chronic and acute form of GVHD. The acute form is presented by painful ulcers, lichenoid lesions affecting practically whole oral cavity, while the chronic GVHD is compared to autoimmune diseases such as Sjögren syndrome. GVHD is a major complication of bone marrow transplantation with risk to health a therapeutic result. The treatment is long-term and involve interdisciplinary cooperation.
Keywords: graft versus host disease; bone marrow transplantation; oral mucositis
Published: September 1, 2011 Show citation
References
- Antin, J. H., Ferrara, J. L.: Cytokine dysregulation and acute graft-versus-host disease. Blood, 80, 1992, s. 2964-2968.
Go to original source...
- Bauer, D. J., Hood, A. F., Horn, T. D.: Histologic comparison of autologous graft-versus-host reaction and cutaneous eruption of lymphocyte recovery. Arch. Dermatol., roč. 129, 1993, č. 7, s. 855-858.
Go to original source...
- Billingham, R. E.: The biology of graft-versus-host reactions. Harvey Lecture, roč. 62 (1966-1967), s. 21-78.
- Clark, J. G., Schwartz, D. A., Flournoy, N., Sullivan, K. M., Crawford, S. W., Thomas, E. D.: Risk factors for airflow obstruction in recipient sof bone marrow transplants. Ann. Intern. Med., roč. 107, 1987, s. 648-656.
Go to original source...
Go to PubMed...
- Dreizen, S., McCredie, K. B., Dickie, K. A., Zander, A. R., Peters, L. J.: Oral complications of bone marrow transplantation in adults with acute leukemia. Postgrad. Med., roč. 66, 1979, s. 187-196.
Go to original source...
Go to PubMed...
- Gorin, N. C., Aegerter, P., Auvert, B., Meloni, G., Goldstone, A. H., Burnett, A., et al.: Autologous bone marrow transplantation for acute myelocytic leukemia in first remision: a European survey of the role of marrow purging. Blood, roč. 75, 1990, s. 1606-1614.
Go to original source...
- Heimdahl, A., Johson, G., Danielsson, K. H., Lonnquist, B., Sundelin, P., Ringden, O.: Oral condition of patients with leukemia and severe aplastic anemia. Oral Surg. Oral Med. Oral Pathol., roč. 60, 1985, s. 498-504.
Go to original source...
Go to PubMed...
- Kolbinson, D. K., Schubert, M. M., Flournoy, N., Truelove, E. L.: Early oral ganges following bone-marrow transplantation. Oral Surg. Oral Med. Oral Pathol., roč. 66, 1988, s. 130-138.
Go to original source...
Go to PubMed...
- Lawley, T. J., Peck, G. L., Moutsopoulos, H. M., Gratwohl., A. A., Deisseroth, A. B.: Sclerodermia, Sjogren's-like syndrome, and chronic graft-versus-host disease. Ann. Intern. Med., roč. 87, 1977, s. 707-709.
Go to original source...
Go to PubMed...
- McCullough, J., Hansen, J., Perkins, H., Stroncek, D., Bartsch, G.: The National Marrow Donor Program: how it works, accomplishments to date. Oncology, 1989, 3, s. 63-68.
Go to PubMed...
- Nash, R. A., Etzioni, R., Storb, R., Furlong, T., Gooley, T., Anasetti, C.: Tacrolimus (FK 506) alone or in combination with methotrexate or methylprednisolon for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single center study. Blood, roč. 85, 1995, s. 3746-3753.
Go to original source...
- Saral, R., Burns, W. H., Laskin, O. L., Santos, G. W., Lietman, P. S.: A randomized double-blind controlled trial in bone-marrow recipients. N. Engl. J. Med., roč. 305, 1981, s. 63-67.
Go to original source...
Go to PubMed...
- Schubert, M. M., Sullivan, K. M., Morton, T. H., Izutsu, K. T., Peterson, D. E., Flournoy, N., et al.: Oral manifestation of chronic graft-versus-host disease. Arch. Intern. Med., roč. 144, 1984, s. 1591-1595.
Go to original source...
- Singhal, S., Mehta, J., Rattenbury, H., Treleaven, J., Powles, R.: Oral pilocarpine hydrochlorid for the treatment of refractory xerostomia associated with chronic graft-versus-host disease. Blood, roč. 85, 1995, s. 1147-1148.
Go to original source...
- Storb, R., Deeg, H. J., Pepe, M., Appelbaum, F., Anasetti, C., Beatty, P.: Methotrexate et cyclosporin versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial. Blood, roč. 73, 1989, s. 1729-1734.
Go to original source...
- Sullivan, K. M., Shulman, H. M., Storb, R., Weiden, P. L., McDonald, R. P., Whiterspoon, R. P., et al.: Chronic graft-versus-host disease in 52 patients: adverse natural course and succesful treatment with combination immunosuppression. Blood, roč. 57, 1981, s. 267-276.
Go to original source...
- Unanue, E. R., Allen, P. M.: The basis for the immunoregulatory role of macrophages and other accessory cells. Science, roč. 236, 1987, s. 551-557.
Go to original source...
Go to PubMed...
- Vogelsang, G. B., Hess, A. D., Santos, G. W.: Acute graft-versus-host disease: clinical characteristic in the cyclosporine era. Medicine (Baltimore), roč. 67, 1988, č. 3, s. 163-174.
Go to original source...
Go to PubMed...
- Volc-Platzer, B., Honigsmann, H., Hinterberger, W., Wollf, K.: Photochemotherapy improves chronic cutaneous, graft-versus-host disease. J. Am. Acad. Dermatol., roč. 23, 1990, s. 220-228.
Go to original source...
Go to PubMed...
- Weiden, P. L., Sullivan, K. M., Flournoy, N., Storb, R., Thomas, E. D.: Seattle Marrow Transplant Team. Antileukemic effect of chronic graft-versus-host disease contribution to improved survival after allogeneic marrow transplantation. N. Engl. J. Med., roč. 304, 1981, s. 1529-1533.
Go to original source...
Go to PubMed...
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.